Henry McCusker's  Instablog

Henry McCusker
Send Message
Analyst, Journalist and Publisher ... Henry enters his tenth (10) year at Scimitar Equity -Regenerative Medicine Investors which aggregates, curates and creates bottom-line content weeding of regenerative medicine and cell therapy news to provide a customized, vetted selection of relevant and... More
My company:
Scimitar Equity-Regenerative Medicine Investors
My blog:
Scimitar Equity Blog
  • Aastrom (ASTM) Names Dan Orlando Interim CEO 0 comments
    Dec 12, 2012 10:07 AM

    The leadership transition …

    ASTM's company's board of directors has named Dan Orlando interim CEO of Aastrom.

    Mr. Orlando, who joined Aastrom as chief commercial officer in August, will assume the position of interim CEO effective 12/14/12. Aastrom's President and CEO Tim Mayleben is retiring but will remain an active member of the board of directors.

    The Bottom Line: Interim CEO, Dan Orlando brings a depth of experience in the development and commercialization of cardiovascular and metabolic therapies that will help ASTM to continue moving forward. Mr. Mayleben will continue to support the transition to a permanent CEO. I am not the only one to say - "Great Move"; Steve Brozak of WBB Securities also signaled the same message in a call … "Dan past deal structure successes <especially having worked for a Japanese entity - Taketa, North America where negotiation skills are truly driven> and experience should further focus … ASTM's ability to drive significant value to this disease state franchise"! ASTM closed DOWN yesterday … at $1.30 but, is up $0.02 <+1.54%> to $1.32 at the open with a tighter mid-day range of $1.29 - $1.32 but, is settling at $1.30. I have NOT given up as ASTM has been getting "hammered" on filings of stock sales but, they are … related to the warrant swaps … which other companies have been … unable … to recognize with their "muddied" balance sheets! I have maintained a "BUY" in this market and at this pricing because of the late stage trial status even with a dwindling RegMed universe pricing and visibility. As the BOD … fulfills its responsibility … they will make this appointment permanent in the New Year !

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Back To Henry McCusker's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


  • ImmunoCellular (OTC BB: IMUC) files to Sell $13.8M of Units via Cowen
    Nov 30, 2011
  • Mid-Day Movers: BioTime (AMEX: BTX), Cytori (CYTX), Geron (GERN), Neuralstem (AMEX: CUR), ReNeuron (RENE.LON), ThermoGenesis (KOOL)
    Oct 26, 2011
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.